Literature DB >> 16291038

Peyronie's disease: etiology, epidemiology and medical treatment.

Jason M Greenfield1, Laurence A Levine.   

Abstract

The investigation of medical options for the treatment of Peyronie's disease is lacking controlled clinical trials with uniform standardized assessments and objective measures of deformity, including curvature and circumference. A key to defining the beneficial effects of various medical therapies lies in standardizing the evaluation of the Peyronie's patient across various studies so that the proposed benefits can be confirmed and applied to all populations. Furthermore, basic science research into the pathophysiology of this disorder is likely to yield new insights into potential treatment options and direct future therapies.

Entities:  

Mesh:

Year:  2005        PMID: 16291038     DOI: 10.1016/j.ucl.2005.08.011

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  12 in total

1.  Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?

Authors:  Benjamin N Breyer; Alan W Shindel; Yun-Ching Huang; Michael L Eisenberg; Dana A Weiss; Tom F Lue; James F Smith
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

Review 2.  Peyronie's Disease: Intralesional Therapy and Surgical Intervention.

Authors:  Louis A Aliperti; Akanksha Mehta
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

Review 3.  Prophylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie's patients.

Authors:  Pengbo Jiang; Athena Christakos; Mina Fam; Hossein Sadeghi-Nejad
Journal:  Korean J Urol       Date:  2014-10-10

4.  A novel modification of tunical plication by plaque thinning: long-term results in treating penile curvature of Peyronie's disease.

Authors:  Sentai Ding; Jiajü Lü; Hui Zhang; Lijing Wei; Kejia Ding
Journal:  Int Urol Nephrol       Date:  2009-11-24       Impact factor: 2.370

5.  The histopathological effects of intracavernosal mitomycin-C injection in a rat Peyronie's disease model.

Authors:  Engin Kaya; Yusuf Kibar; Sercan Yilmaz; Ayhan Ozcan; Burak Kopru; Turgay Ebiloglu; Hasan Cem Irkilata
Journal:  Can Urol Assoc J       Date:  2017-11       Impact factor: 1.862

6.  Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.

Authors:  M Shirazi; A R Haghpanah; M Badiee; M A Afrasiabi; S Haghpanah
Journal:  Int Urol Nephrol       Date:  2009-02-06       Impact factor: 2.370

7.  A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States.

Authors:  Dana Britt Dibenedetti; Dat Nguyen; Laurie Zografos; Ryan Ziemiecki; Xiaolei Zhou
Journal:  Adv Urol       Date:  2011-10-23

8.  Review of the surgical approaches for Peyronie's disease: corporeal plication and plaque incision with grafting.

Authors:  Viet Q Tran; Dennis H Kim; Timothy F Lesser; Sherif R Aboseif
Journal:  Adv Urol       Date:  2008-11-04

Review 9.  A critical analysis of the surgical outcomes for the treatment of Peyronie's disease.

Authors:  Sree H Mandava; Landon W Trost; Wayne J G Hellstrom
Journal:  Arab J Urol       Date:  2013-05-06

Review 10.  Role of collagenase clostridium histolyticum in Peyronie's disease.

Authors:  Taylor C Peak; Gregory C Mitchell; Faysal A Yafi; Wayne J Hellstrom
Journal:  Biologics       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.